Is it time to abandon RHAMM/HMMR as a candidate antigen for immunotherapy of acute myeloid leukemia?

Schendel, Dolores J

Is it time to abandon RHAMM/HMMR as a candidate antigen for immunotherapy of acute myeloid leukemia? [electronic resource] - Haematologica Oct 2012 - 1454-5 p. digital

Publication Type: Editorial; Research Support, Non-U.S. Gov't; Comment

1592-8721

10.3324/haematol.2012.077099 doi


Animals
Extracellular Matrix Proteins--immunology
Female
Humans
Hyaluronan Receptors--immunology
Leukemia, Myeloid, Acute--immunology
Male